Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Vitamin D deficiency is considered a risk factor for the development of TB.
Source: TB Risk Factors. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Narrative review.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Tuberculosis in Sudan: A Comprehensive Narrative Review of Epidemiological Trends, Diagnosis, Drug Resistance, Challenges, and Data Gaps
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Tuberculosis in Sudan: A Comprehensive Narrative Review of Epidemiological Trends, Diagnosis, Drug Resistance, Challenges, and Data Gaps
Narrative review · Health Science Reports · 2026
Original publication title
Tuberculosis in Sudan: A Comprehensive Narrative Review of Epidemiological Trends, Diagnosis, Drug Resistance, Challenges, and Data Gaps
© 2026 The Author(s). Health Science Reports published by Wiley Periodicals LLC.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: Background and Aims
This narrative review aims to provide a comprehensive overview of tuberculosis (TB) in Sudan, focusing on prevalence, drug resistance patterns, and associated challenges while identifying knowledge gaps in scientific research and data needed for effective management.
Source: Background and AimsAbstract: What methods does the paper describe?
A comprehensive literature search was conducted using PubMed, Scopus, Web of Science, and Google Scholar without language or date restrictions. Thirty‐two studies and TB notification data from 2009 to 2025 were analyzed.
Source: MethodsAbstract: Results
Among 32 studies, 41% (13/32) addressed TB prevalence and 59% (19/32) explored drug resistance. Kassala State reported the highest pulmonary TB prevalence (70%), while Khartoum had 17%. Drug‐resistant TB was more prevalent in Khartoum (41.5%) than Kassala (21.4%). Only 23 studies examined HIV coinfections. TB notifications declined from 209 per 100,000 in 2009 to 10 per 100,000 in 2019 but increased to 50 per 100,000 after the COVID‐19 pandemic. Data were lacking for Sudan's western states. Because of the Sudan war, in 2024, 14,310 cases were reported.
Source: ResultsAbstract: Conclusion
This review underlines the scarcity of TB research in Sudan and highlights the urgent need for an integrated health information system to generate accurate, updated data for timely interventions.
Source: ConclusionAuthors’ abstract
ABSTRACT
Background and Aims
This narrative review aims to provide a comprehensive overview of tuberculosis (TB) in Sudan, focusing on prevalence, drug resistance patterns, and associated challenges while identifying knowledge gaps in scientific research and data needed for effective management.
Methods
A comprehensive literature search was conducted using PubMed, Scopus, Web of Science, and Google Scholar without language or date restrictions. Thirty‐two studies and TB notification data from 2009 to 2025 were analyzed.
Results
Among 32 studies, 41% (13/32) addressed TB prevalence and 59% (19/32) explored drug resistance. Kassala State reported the highest pulmonary TB prevalence (70%), while Khartoum had 17%. Drug‐resistant TB was more prevalent in Khartoum (41.5%) than Kassala (21.4%). Only 23 studies examined HIV coinfections. TB notifications declined from 209 per 100,000 in 2009 to 10 per 100,000 in 2019 but increased to 50 per 100,000 after the COVID‐19 pandemic. Data were lacking for Sudan's western states. Because of the Sudan war, in 2024, 14,310 cases were reported.
Conclusion
This review underlines the scarcity of TB research in Sudan and highlights the urgent need for an integrated health information system to generate accurate, updated data for timely interventions.
Publication and source details
Original title: Tuberculosis in Sudan: A Comprehensive Narrative Review of Epidemiological Trends, Diagnosis, Drug Resistance, Challenges, and Data Gaps
Mohammad Azhar Kamal; Hisham N. Altayb; Shima M. Abdulgader; Ehssan Moglad
Health Science Reports · 2026
* Correspondence: Ehssan Moglad (ehssanhassn@gamil.com)© 2026 The Author(s). Health Science Reports published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Deanship of Scientific Research, Prince Sattam bin Abdulaziz University PSAU/2025/03/34120
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:40:50.456325+00:00
DOI: 10.1002/hsr2.73010 · PMC13575636